2000
DOI: 10.1080/080370500453528
|View full text |Cite
|
Sign up to set email alerts
|

Regional Renal Haemodynamics of Angiotensin II Infusion under Prostaglandin, Kinin or Converting Enzyme Inhibition in the Wistar Rat

Abstract: Bradykinin and prostaglandins do not appear to cause the lack of renal papillary vasoconstriction to Ang II. However, the increase in PBF to Ang II seen after enalapril treatment suggests that enalapril treatment, possibly via its effects on kinin breakdown and subsequent NO formation, might affect the sensitivity of renal papillary autoregulation. This may be an important aspect of the blood pressure lowering effect of ACE inhibitors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
1

Year Published

2002
2002
2011
2011

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 7 publications
0
3
1
Order By: Relevance
“…However, in a later study they found that angiotensin converting enzyme inhibition (CEI) increased GFR in deep, but not in superficial glomeruli (Göransson & Sjöquist, 1985), and also increased free flow pressure in the loops of Henle but not in superficial proximal tubules (Göransson et al 1986). That is opposite to the relative fall in inner cortical filtration rate induced by losartan in the present study, possibly due to increased kinin formation induced by inhibition of converting enzyme (Nobes et al 1991; Rudenstam et al 2000) and not by losartan.…”
Section: Discussioncontrasting
confidence: 99%
“…However, in a later study they found that angiotensin converting enzyme inhibition (CEI) increased GFR in deep, but not in superficial glomeruli (Göransson & Sjöquist, 1985), and also increased free flow pressure in the loops of Henle but not in superficial proximal tubules (Göransson et al 1986). That is opposite to the relative fall in inner cortical filtration rate induced by losartan in the present study, possibly due to increased kinin formation induced by inhibition of converting enzyme (Nobes et al 1991; Rudenstam et al 2000) and not by losartan.…”
Section: Discussioncontrasting
confidence: 99%
“…Intravenous administration of ANG II did not affect inner medullary blood flow in control rats and those pretreated with L-NAME but decreased it in indomethacin-pretreated rats, indicating that within the inner medulla, PGs, but not NO, seem to counteract the vasopressor effect of circulating ANG II (Badzynska et al, 2003). Rudenstam et al (2000) provided evidence suggesting that the increase in papillary blood flow in rats to ANG II seen after enalapril treatment is mediated possibly via effects of the ACE inhibitor on kinin breakdown and NO formation. In SHR, low-dose ANG II reduced renal medullary blood flow, and this effect was abolished by L-arginine given into the renal medulla; in SHR treated with enalapril for 10 weeks, ANG II did not alter the blood flow, but sensitivity to ANG II was unmasked after L-NAME was infused into the renal medulla ).…”
Section: In Vivo Study In Ratsmentioning
confidence: 99%
“…In rats and rabbits, infusions of angiotensin II reduce total renal blood flow (RBF) and cortical blood flow but have a lesser effect on medullary blood flow (MBF). [2][3][4][5] Angiotensin II can even increase MBF, especially when administered as a bolus. 6 -8 Nitric oxide synthase and/or cyclooxygenase blockade can enhance angiotensin II-induced reductions in MBF and abolish angiotensin II-induced increases in MBF, both of which are chiefly AT 1 mediated.…”
mentioning
confidence: 99%